PubRank

Adoptive Transfer of Autologous T Cells Targeted to Prostate Specific Membrane Antigen (PSMA) for the Treatment of Castrate Metastatic Prostate Cancer (CMPC)

Clinical Trial ID NCT01140373

PubWeight™ 19.45‹?›

🔗 Visit the ClinicalTrials.gov page for NCT01140373

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Adoptive immunotherapy for cancer or viruses. Annu Rev Immunol 2014 1.61
2 Engineered T cells: the promise and challenges of cancer immunotherapy. Nat Rev Cancer 2016 1.51
3 Trial watch: Chemotherapy with immunogenic cell death inducers. Oncoimmunology 2012 1.33
4 Trial Watch: Adoptive cell transfer immunotherapy. Oncoimmunology 2012 1.18
5 Driving CAR T-cells forward. Nat Rev Clin Oncol 2016 1.09
6 Molecular pathways and targets in prostate cancer. Oncotarget 2014 1.00
7 Antigen-Specific T-Cell Activation Independently of the MHC: Chimeric Antigen Receptor-Redirected T Cells. Front Immunol 2013 0.98
8 Manufacture of tumor- and virus-specific T lymphocytes for adoptive cell therapies. Cancer Gene Ther 2015 0.97
9 Making Better Chimeric Antigen Receptors for Adoptive T-cell Therapy. Clin Cancer Res 2016 0.95
10 Immunotherapy for prostate cancer: lessons from responses to tumor-associated antigens. Front Immunol 2014 0.92
11 Chimeric antigen receptor-engineered T cells for the treatment of metastatic prostate cancer. BioDrugs 2015 0.86
12 Immunotherapy of malignant disease using chimeric antigen receptor engrafted T cells. ISRN Oncol 2012 0.84
13 Immunotherapy for solid tumors--a review for surgeons. J Surg Res 2013 0.83
14 Genetically engineered T cells for the treatment of cancer. J Intern Med 2013 0.83
15 Progress in oncolytic virotherapy for the treatment of thyroid malignant neoplasm. J Exp Clin Cancer Res 2014 0.80
16 PSMA-specific CAR-engineered T cells eradicate disseminated prostate cancer in preclinical models. PLoS One 2014 0.80
17 Immunotherapy for prostate cancer: False promises or true hope? Cancer 2016 0.78
18 New Strategies for the Treatment of Solid Tumors with CAR-T Cells. Int J Biol Sci 2016 0.77
19 Immune Therapy for Prostate Cancer. Cancer J 2016 0.76
20 Chimeric antigen receptors and bispecific antibodies to retarget T cells in pediatric oncology. Pediatr Blood Cancer 2015 0.75
21 A Perspective of Immunotherapy for Prostate Cancer. Cancers (Basel) 2016 0.75
Next 100